Cargando…

Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: A case report

RATIONALE: Oncocytic Schneiderian papillomas (OSP) are an uncommon type of sinonasal papillomas that arise from the Schneiderian epithelium, accounting for only 6% of all sinonasal papillomas. Malignancies arising in OSP are rare and are almost always described as in situ or invasive squamous cell c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lichuan, Hu, Chunhua, Zheng, Xiaodan, Wu, Dawei, Sun, Haili, Yu, Wei, Wu, Ying, Chen, Dong, Lv, Qianwen, Zhang, Ping, Li, Xiping, Liu, Honggang, Wei, Yongxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999462/
https://www.ncbi.nlm.nih.gov/pubmed/29879069
http://dx.doi.org/10.1097/MD.0000000000011025
_version_ 1783331429585780736
author Zhang, Lichuan
Hu, Chunhua
Zheng, Xiaodan
Wu, Dawei
Sun, Haili
Yu, Wei
Wu, Ying
Chen, Dong
Lv, Qianwen
Zhang, Ping
Li, Xiping
Liu, Honggang
Wei, Yongxiang
author_facet Zhang, Lichuan
Hu, Chunhua
Zheng, Xiaodan
Wu, Dawei
Sun, Haili
Yu, Wei
Wu, Ying
Chen, Dong
Lv, Qianwen
Zhang, Ping
Li, Xiping
Liu, Honggang
Wei, Yongxiang
author_sort Zhang, Lichuan
collection PubMed
description RATIONALE: Oncocytic Schneiderian papillomas (OSP) are an uncommon type of sinonasal papillomas that arise from the Schneiderian epithelium, accounting for only 6% of all sinonasal papillomas. Malignancies arising in OSP are rare and are almost always described as in situ or invasive squamous cell carcinoma, although mucoepidermoid, small cell carcinoma and sinonasal undifferentiated carcinoma have also been reported. To our knowledge, only 18 such instances have been reported in the medical literature. PATIENT CONCERNS: Here, we report the case of an 81-year-old man presenting with a left sinonasal neoplasm, who had undergone 4 operations. The first postoperative pathology revealed a benign nasal polyp. The following several postoperative pathology revealed a novel, human papillomavirus-negative adenocarcinoma with increasing malignant features with each recurrence arising in an OSP. In addition, the most recent recurrences were associated with metastasis of cervical lymph nodes. And after the operation, the patient refused adjuvant radiotherapy. On 6-month follow-up after the last operation, the patient developed an in situ tumor recurrence 1 month after the fourth operation and refused to undergo surgery again. DIAGNOSIS: Immunohistochemistry for Ki67, CK7, CK5/6, P53, and P63 showed a progression of malignancy. HPV assay presented the 21 most prevalent HPV types were negative. In addition, KRAS gene exon 2 G12C presented mutation in the OSP-associated adenocarcinoma. INTERVENTIONS: During the whole course of the patient's disease, we performed four nasal endoscopic operations. And after the last operation, the patient refused adjuvant radiotherapy and KRAS-targeted therapy. OUTCOMES: We are the first to describe adenocarcinoma arising in an OSP. To our surprise, from the first benign neoplasm to the second OSP-associated adenocarcinoma, it went through a long period of 10 years. However, after the adenocarcinogenesis, the differentiation of tumor became worse with the shorter interval of each recurrence. LESSONS: Therefore, for elderly patients with unilateral nasal polyps, long-term follow-up is necessary. Once OSP turns into malignant, radical resection should be performed as much as possible to reduce the irritability of tumors.
format Online
Article
Text
id pubmed-5999462
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-59994622018-06-20 Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: A case report Zhang, Lichuan Hu, Chunhua Zheng, Xiaodan Wu, Dawei Sun, Haili Yu, Wei Wu, Ying Chen, Dong Lv, Qianwen Zhang, Ping Li, Xiping Liu, Honggang Wei, Yongxiang Medicine (Baltimore) Research Article RATIONALE: Oncocytic Schneiderian papillomas (OSP) are an uncommon type of sinonasal papillomas that arise from the Schneiderian epithelium, accounting for only 6% of all sinonasal papillomas. Malignancies arising in OSP are rare and are almost always described as in situ or invasive squamous cell carcinoma, although mucoepidermoid, small cell carcinoma and sinonasal undifferentiated carcinoma have also been reported. To our knowledge, only 18 such instances have been reported in the medical literature. PATIENT CONCERNS: Here, we report the case of an 81-year-old man presenting with a left sinonasal neoplasm, who had undergone 4 operations. The first postoperative pathology revealed a benign nasal polyp. The following several postoperative pathology revealed a novel, human papillomavirus-negative adenocarcinoma with increasing malignant features with each recurrence arising in an OSP. In addition, the most recent recurrences were associated with metastasis of cervical lymph nodes. And after the operation, the patient refused adjuvant radiotherapy. On 6-month follow-up after the last operation, the patient developed an in situ tumor recurrence 1 month after the fourth operation and refused to undergo surgery again. DIAGNOSIS: Immunohistochemistry for Ki67, CK7, CK5/6, P53, and P63 showed a progression of malignancy. HPV assay presented the 21 most prevalent HPV types were negative. In addition, KRAS gene exon 2 G12C presented mutation in the OSP-associated adenocarcinoma. INTERVENTIONS: During the whole course of the patient's disease, we performed four nasal endoscopic operations. And after the last operation, the patient refused adjuvant radiotherapy and KRAS-targeted therapy. OUTCOMES: We are the first to describe adenocarcinoma arising in an OSP. To our surprise, from the first benign neoplasm to the second OSP-associated adenocarcinoma, it went through a long period of 10 years. However, after the adenocarcinogenesis, the differentiation of tumor became worse with the shorter interval of each recurrence. LESSONS: Therefore, for elderly patients with unilateral nasal polyps, long-term follow-up is necessary. Once OSP turns into malignant, radical resection should be performed as much as possible to reduce the irritability of tumors. Wolters Kluwer Health 2018-06-18 /pmc/articles/PMC5999462/ /pubmed/29879069 http://dx.doi.org/10.1097/MD.0000000000011025 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Zhang, Lichuan
Hu, Chunhua
Zheng, Xiaodan
Wu, Dawei
Sun, Haili
Yu, Wei
Wu, Ying
Chen, Dong
Lv, Qianwen
Zhang, Ping
Li, Xiping
Liu, Honggang
Wei, Yongxiang
Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: A case report
title Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: A case report
title_full Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: A case report
title_fullStr Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: A case report
title_full_unstemmed Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: A case report
title_short Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: A case report
title_sort oncocytic schneiderian papilloma-associated adenocarcinoma and kras mutation: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999462/
https://www.ncbi.nlm.nih.gov/pubmed/29879069
http://dx.doi.org/10.1097/MD.0000000000011025
work_keys_str_mv AT zhanglichuan oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT huchunhua oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT zhengxiaodan oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT wudawei oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT sunhaili oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT yuwei oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT wuying oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT chendong oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT lvqianwen oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT zhangping oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT lixiping oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT liuhonggang oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport
AT weiyongxiang oncocyticschneiderianpapillomaassociatedadenocarcinomaandkrasmutationacasereport